慢性肾脏病

杨洪涛运用附子组方治疗慢性肾脏病临床经验

Clinical Experience on Treatment of CKD With Aconite Composing Prescriptions by Yang Hong Tao

各亚组，包括慢性肾脏病的不同阶段，显示一致的治疗效果。

Various subgroups , including those based on different stages of CKD , showed consistent treatment effects .

血清胱抑素C评价慢性肾脏病患者早期肾功能损害的临床研究

Serum Cystatin C as a Marker for Detection of Early Renal Disfunction in Patients with Chronic Kidney Disease

慢性肾脏病患者基因组DNA整体甲基化与血浆非对称性二甲基精氨酸关系研究

The Relationship between Global DNA Methylation and Plasma Asymmetric Dimethylarginine in Patients with Chronic Kidney Disease

慢性肾脏病患者不同肾损害时期血清胱抑素C的水平探讨

A study on levels of serum cystatin C in different stages of renal impairment in patients with chronic kidney disease

多状态Markov模型在慢性肾脏病分级预后研究中的应用

Application of Markov model in studying graded prognosis of chronic kidney disease

尿CystatinC在慢性肾脏病中的诊断价值

Value of Application of Urinary Cystatin C for Diagnosing Chronic Kidney Disease

维生素E干预对静脉补铁慢性肾脏病大鼠氧化应激的影响

The effects of vitamin E supplementation on oxidative stress in rats with adenine-induced kidney disease receiving intravenous iron therapy

健康人群血清半胱氨酸蛋白酶抑制剂C与肌酐分布及其评价慢性肾脏病患者肾小球滤过功能的比较研究

Reference values of serum Cystatin C and creatinine in healthy volunteers , and comparison of their evaluation of glomerular filtration function in chronic renal patients

血清CystatinC评价慢性肾脏病患者肾小球滤过功能的对照研究

Study on Serum Cystatin C for the Evaluation Glomerular Filtration Rate in Chronic Kidney Disease

目的：心血管合并症是慢性肾脏病（ChronicKidneyDisease，CKD）病人最主要的死亡原因之一。

Objective : Cardiovascular complication is one of the main causes of death of Chronic Kidney Disease ( CKD ) patients .

目的探讨血清胱抑素C（CystatinC）在评价慢性肾脏病患者早期肾功能损害中的临床价值。

Objective : To evaluate the applicability of serum cystatin C as a endogenous marker for detection of early renal disfunction in patients with chronic kidney disease .

慢性肾脏病患者血清TGFβ1、血清纤维化指标与心肾功能关系的研究

The Study of Relationship between TGF - β 1 and Serum Marker for Fibrosis , Renal Function , Cardiac Function in Chronic Kidney Disease Patients

目的：探讨包括轻度肾损害在内的慢性肾脏病（CKD）与冠心病（CAD）的相关性。

Objective : To investigate the correlation between coronary artery disease ( CAD ) and chronic kidney disease including minor renal dysfunction .

慢性肾脏病（CKD）是一类严重影响人类健康的疾病。

Chronic kidney disease ( CKD ) is a serious disease with high morbidity .

ACE抑制剂预防CAN的临床研究增大剂量的福辛普利治疗慢性肾脏病轻中度蛋白尿的前瞻性研究

Angiotensin converting enzyme inhibitor administration for preventing CAN Prospective clinic study of increasing doses of angiotensin converting enzyme inhibitor fosinopril in patients with mild proteinuria

Logistic回归分析显示老龄、HbA1c升高、血肌酐、胆固醇升高、高血压患者、出现蛋白尿均是慢性肾脏病的危险因素。

The logistic regression analysis showed that the risk factors of CKD were age , HbA1c , creatinine , cholesterol , hypertension , proteinuria .

CystatinC与其它内源性标志物在轻&中度慢性肾脏病患者肾小球滤过率评估中的比较研究

Comparative Research of Serum Cystatin C and the Other Endogenous Markers in Glomerular Filtration Rate Measurement in Chronic Kidney Disease Patients with Mild to Moderate Impairment of Kidney Function

[背景／目的]本文分为3部分。首先，我们综述了肾炎康复片治疗慢性肾脏病（ChronicKidneyDisease，CKD）的研究概况。

[ Background / Aims ] In this article , the first , we reviewed the progression in the treatment of chronic kidney disease ( CKD ) with Shen yan kang fu tablet .

肠内营养对全胃切除术后恢复的疗效评估慢性肾脏病患者营养状态调查及eGFR的评估探讨

The Efficacy Evaluation of Enteral Nutrition in Patients with Gastric Carcinoma after Operation The Hospitalization-based Investigation and Analysis about Condition and eGFR on CKD Subjects

目的了解我国慢性肾脏病（CKD）患者心血管疾病（CVD）的危险因素。脉压与心血管疾病（综述）

Objective To identify the risk factors associated with cardiovascular disease ( CVD ) in Chinese chronic kidney disease ( CKD ) patients .

结论：1.慢性肾脏病患者，随着肾功能的损害，血、尿Col-Ⅳ和LN的含量均明显增高，Col-Ⅳ、LN均参与了肾小球硬化的病理过程；

Conclusions : 1 . With the lesion of the renal function , the contents of serum , urinary Col-IV LN increased significantly in Chronic nephropathy patients .

钙磷乘积增加与慢性肾脏病患者的充血性心力衰竭（CHF）有关（OR1.023，CI1.01～1.03）；

There was a significant interaction between the calcium-phosphate product and congestive heart failure ( CHF ) ( OR 1.023 , CI 1.01 ~ 1.03 ) .

目的评价肾小球滤过率（GFR）评估方程在慢性肾脏病（CKD）患者不同分期中的适用性。

Objective To understand the applicability of MDRD equation in Chinese patients with chronic kidney disease ( CKD ) .

DDAH基因多态性调控ADMA与慢性肾脏病关系的临床研究

Clinical Research on the Relationship between DDAH Gene Polymorphisms Regulating ADMA and Chronic Kidney Disease

蛋白尿不仅是慢性肾脏病（CKD）临床重要指征之一，也是加重肾脏疾患的关键因素之一。

Proteinuria is not only a sign of chronic renal disease ( CKD ), but also a factor that aggravates the progress of kidney diseases .

第2~3期轻度慢性肾脏病患者的CAD（59%）和CVA（10%）患病率已明显高于同地区一般人群；

The cohort with minor renal dysfunction ( stage 2-3 ) had higher prevalence of CAD ( 5.9 % ) and CVA ( 1.0 % ) compared with general population in the same regions .

MDRD方程在我国慢性肾脏病患者中的改良和评估

Modification and evaluation of MDRD estimating equation for Chinese patients with chronic kidney disease

目的观察慢性肾脏病（CKD）患者24h血压动态变化，探讨昼夜节律异常与肾功能损害的关系。

Objective To observe the change of 24-hour blood pressure and to explore the relation between abnormality of circadian rhythm and renal injury in patients with chronic kidney disease .

方法采用酶连免疫吸附试验（EnzymeLinkedImmunosorbentassay，ELISA）检测健康者及纤维化程度不同的慢性肾脏病患者血清和尿胱抑素C浓度。

Cystatin C assay in serum and urine helps to predict the progress of chronic renal disease Methods : The serum and urine CC concentration in all patients and ten health people were measured by enzyme linked immunosorbent assay ( ELISA ) .